Quarterly Report · 10-Q
Zevra Therapeutics, Inc.
ZVRANASDAQEQUITYCurrent
Quarterly Report
Company context
Zevra Therapeutics, Inc. is a commercial-stage company with a late-stage pipeline committed to redefining what is possible in bringing life-changing therapies to people living with rare diseases. The Company is focused on broadening access through geographic expansion opportunities, progressing its pipeline toward key milestones, and delivering meaningful therapeutics. The commercialization of its lead product, marketed in the U.S. for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a strong corporate foundation and validates its ability to advance therapies from development to market. Zevra's vision is realized through disciplined execution of its strategic plan and core values - patient centricity, integrity, accountability, innovation, and courage - which guide its efforts to deliver long-term value.
Current securities
Historical securities (1)
Recent company filings
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗